Difference between revisions of "Part:BBa K3117020"
| Line 10: | Line 10: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell | + | CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell (Chetty et al., 1994). |
| + | |||
| + | ===References=== | ||
| + | |||
| + | 1. Chetty, R.; Gatter, K. (1994): CD3: structure, function, and role of immunostaining in clinical practice. In: The Journal of pathology 173 (4), S. 303–307. DOI: 10.1002/path.1711730404. | ||
Revision as of 23:02, 21 October 2019
scFv VH against CD3 codon optimized for CHO expression
Part BBa_K3117020 is a single chain variable fragment (scFv) of the anti-CD3 antibody. This fragment was used to generate a fusion protein to create a bispecific antibody on the one hand driected against CD3, on the other part against GPA33.
Usage and Biology
CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell (Chetty et al., 1994).
References
1. Chetty, R.; Gatter, K. (1994): CD3: structure, function, and role of immunostaining in clinical practice. In: The Journal of pathology 173 (4), S. 303–307. DOI: 10.1002/path.1711730404.